323 related articles for article (PubMed ID: 30561555)
1. Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction.
Peghin M; Los-Arcos I; Hirsch HH; Codina G; Monforte V; Bravo C; Berastegui C; Jauregui A; Romero L; Cabral E; Ferrer R; Sacanell J; Román A; Len O; Gavaldà J
Clin Infect Dis; 2019 Sep; 69(7):1192-1197. PubMed ID: 30561555
[TBL] [Abstract][Full Text] [Related]
2. Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study.
Sweet SC; Chin H; Conrad C; Hayes D; Heeger PS; Faro A; Goldfarb S; Melicoff-Portillo E; Mohanakumar T; Odim J; Schecter M; Storch GA; Visner G; Williams NM; Kesler K; Danziger-Isakov L
Am J Transplant; 2019 Dec; 19(12):3284-3298. PubMed ID: 31216376
[TBL] [Abstract][Full Text] [Related]
3. Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation.
Allyn PR; Duffy EL; Humphries RM; Injean P; Weigt SS; Saggar R; Shino MY; Lynch JP; Ardehali A; Kubak B; Tseng CH; Belperio JA; Ross DJ; Gregson AL
Transplantation; 2016 Nov; 100(11):2424-2431. PubMed ID: 27467538
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.
Fisher CE; Preiksaitis CM; Lease ED; Edelman J; Kirby KA; Leisenring WM; Raghu G; Boeckh M; Limaye AP
Clin Infect Dis; 2016 Feb; 62(3):313-319. PubMed ID: 26565010
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study.
Peghin M; Hirsch HH; Len Ó; Codina G; Berastegui C; Sáez B; Solé J; Cabral E; Solé A; Zurbano F; López-Medrano F; Román A; Gavaldá J
Am J Transplant; 2017 May; 17(5):1304-1312. PubMed ID: 27615811
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
[TBL] [Abstract][Full Text] [Related]
7. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study.
Gottlieb J; Schulz TF; Welte T; Fuehner T; Dierich M; Simon AR; Engelmann I
Transplantation; 2009 May; 87(10):1530-7. PubMed ID: 19461490
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
9. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
Gallagher HM; Sarwar G; Tse T; Sladden TM; Hii E; Yerkovich ST; Hopkins PM; Chambers DC
J Heart Lung Transplant; 2015 Nov; 34(11):1442-8. PubMed ID: 26186804
[TBL] [Abstract][Full Text] [Related]
10. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
[TBL] [Abstract][Full Text] [Related]
11. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
[TBL] [Abstract][Full Text] [Related]
12. Effect of hypogammaglobulinemia on the incidence of community-acquired respiratory viral infections after lung transplantation.
Noell BC; Dawson KL; Seethamraju H
Transplant Proc; 2013; 45(6):2371-4. PubMed ID: 23747186
[TBL] [Abstract][Full Text] [Related]
13. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
14. Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.
Combs MP; Wheeler DS; Luth JE; Falkowski NR; Walker NM; Erb-Downward JR; Lama VN; Dickson RP
Lancet Respir Med; 2021 Jun; 9(6):601-612. PubMed ID: 33460570
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
[TBL] [Abstract][Full Text] [Related]
16. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study.
Testaert H; Bouet M; Valour F; Gigandon A; Lafon ME; Philit F; Sénéchal A; Casalegno JS; Blanchard E; Le Pavec J; Ader F
Clin Microbiol Infect; 2021 Jun; 27(6):897-903. PubMed ID: 32827713
[TBL] [Abstract][Full Text] [Related]
17. Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year.
Permpalung N; Liang T; Gopinath S; Bazemore K; Mathew J; Ostrander D; Durand CM; Shoham S; Zhang SX; Marr KA; Avery RK; Shah PD
J Heart Lung Transplant; 2023 Jul; 42(7):953-963. PubMed ID: 36925381
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
19. Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.
Keller MB; Tian X; Jang MK; Meda R; Charya A; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S
Am J Respir Crit Care Med; 2024 May; 209(10):1238-1245. PubMed ID: 38190701
[No Abstract] [Full Text] [Related]
20. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
